GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Discussion] can we stop arguing about interval stretching until somebody posts a number — 17 comments in the full submission. View in context.
160
c/tapering·submitted 4 months ago by u/vial_math_vera

[Discussion] can we stop arguing about interval stretching until somebody posts a number

Discussionbranch of 6 comments

Asking properly rather than in a comment on somebody else’s thread: can we stop arguing about interval stretching until somebody posts a number. Regained most of it over a year and spent that year assuming it was my fault. It was not; it is what the literature describes. Stopped abruptly once and gradually once. The…

Read the full submission and all 17 comments →

This branch

6 comments, started 4 months ago
u/customs_seizure_sid7 points·4 months ago

the habits are what has to carry it afterwards

replysharereportpermalink
u/nayeli_fonseca3 points·4 months ago

Right, and the habits from the losing phase are the part that has to outlive the dose.

replysharereportpermalink
u/rafael_sjoberg6 points·4 months ago

Small fix — you have described interval stretching and called it a taper. The exposure profiles differ.

replysharereportpermalink
u/vial_math_veraOPsyringe math3 points·4 months ago

The habits are what carried it for a while. When they slipped, everything else followed, in that order.

replysharereportpermalink
u/andres_restrepo1 point·4 months ago

coming back later is allowed and it is common

replysharereportpermalink
u/zeynep_zielinski1 point·4 months ago

Stopped for cost reasons. Appetite came back at about week 2, well before the scale moved, exactly as this board said it would.

replysharereportpermalink

← back to the whole thread

About c/tapering

Stopping on purpose: dose reduction versus interval stretching, what the discontinuation arms of STEP 1 and SURMOUNT-4 actually showed about regain, appetite return timelines, and the people who came off, regained, and went back on without treating it as a failure.

20kmembers
62submissions
Jun 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/tapering rules
  1. Cite the discontinuation data rather than guessing at regain rates.
  2. No shaming people who restart.
  3. Say how long you were on and at what dose before you tapered.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.